Dr. Roxana P Minkus , DO
General Practice • Santa Ana, CA
2650 S Bristol St, Suite 105
Santa Ana, CA 92704
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Roxana Minkus is listed in NPPES under General Practice.
-
NPI assigned on June 18, 2006; this date does not establish years in practice.
-
Published CMS data list 62 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99214 — Established patient outpatient office visit: 48 service units.
- G0439 — Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit: 14 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See the full table · Guide: How to read Medicare Part B data
-
Published CMS data list 5,330 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Atorvastatin Calcium — 776 prescription fills, including refills.
- Metformin Hcl — 483 prescription fills, including refills.
- Alendronate Sodium — 278 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 90 records in the table · Guide: How to read Medicare Part D prescriber data
-
Fewer Medicare Part B services than 85% of clinicians listed under General Practice in California (2024, 411 clinicians with data). Median for this group: 485. Middle half: 154 to 2,031.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 43 in 2020 to 62 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
2650 S Bristol St
Suite 105
Santa Ana, CA 92704
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
College Of Osteo Med Of The Pacific At Pomona
1993
What Public CMS Data Show
General Practice: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
27 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $8,282 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $6,437 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
12,764 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$758,210 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,261.93 across 37 records.
By nature of payment
- Food and Beverage: $1,261.93 across 37 records.
Reporting-company totals (3 largest of 11)
- AstraZeneca Pharmaceuticals LP: $326.83 across 12 records.
- Eli Lilly and Company: $218.37 across 5 records.
- Amgen Inc.: $215.58 across 5 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
33 years (graduated 1993)
CMS Doctors and Clinicians data list 1993 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Minkus has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Minkus as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Santa Ana and California
Billing and prescribing volume is not a quality rating.
Medicare Part B services
Fewer Medicare Part B services than 85% of clinicians listed under General Practice in California (2024, 411 clinicians with data). Median for this group: 485. Middle half: 154 to 2,031.
Too few clinicians listed under General Practice in Santa Ana have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A lower Medicare-allowed amount than 80% of clinicians listed under General Practice in California (2024, 411 clinicians with data). Median for this group: $45,658. Middle half: $14,895 to $165,622.
Too few clinicians listed under General Practice in Santa Ana have Medicare Part B data for 2024 to compare.
Paid by Medicare
A lower Medicare payment amount than 80% of clinicians listed under General Practice in California (2024, 411 clinicians with data). Median for this group: $32,130. Middle half: $11,289 to $132,947.
Too few clinicians listed under General Practice in Santa Ana have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 85% of clinicians listed under General Practice in Santa Ana, CA (2024, 15 clinicians with data). Median for this group: 1,393. Middle half: 76 to 4,206.
More Part D prescriptions than 80% of clinicians listed under General Practice in California (2024, 609 clinicians with data). Median for this group: 755. Middle half: 125 to 3,708.
Part D drug cost
A higher Part D drug cost than 85% of clinicians listed under General Practice in Santa Ana, CA (2024, 15 clinicians with data). Median for this group: $106,239. Middle half: $978 to $558,077.
A higher Part D drug cost than 85% of clinicians listed under General Practice in California (2024, 609 clinicians with data). Median for this group: $49,322. Middle half: $2,066 to $279,323.
28 active clinicians are listed under General Practice with a practice address in Santa Ana, CA (1,964 in California).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Santa Ana
10.7% of these 28 clinicians have the CMS telehealth indicator.
39.3% of these 28 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 44% from 43 in 2020 to 62 in 2024.
- 2020: 43
- 2021: 98
- 2022: 115
- 2023: 109
- 2024: 62
-
Medicare-allowed amount
Medicare-allowed amount increased 157% from $3,227 in 2020 to $8,282 in 2024.
- 2020: $3,227
- 2021: $10,818
- 2022: $14,121
- 2023: $13,641
- 2024: $8,282
-
Paid by Medicare
Paid by Medicare increased 183% from $2,276 in 2020 to $6,437 in 2024.
- 2020: $2,276
- 2021: $7,652
- 2022: $10,302
- 2023: $10,315
- 2024: $6,437
-
Medicare Part D prescriptions
Medicare Part D prescriptions stayed about the same: 5,648 in 2020 and 5,330 in 2024.
- 2020: 5,648
- 2021: 5,692
- 2022: 5,184
- 2023: 5,172
- 2024: 5,330
-
30-day fills
30-day fills stayed about the same: 13,113 in 2020 and 12,764 in 2024.
- 2020: 13,113
- 2021: 13,077
- 2022: 12,313
- 2023: 12,348
- 2024: 12,764
-
Part D drug cost
Part D drug cost increased 64% from $461,763 in 2020 to $758,210 in 2024.
- 2020: $461,763
- 2021: $457,654
- 2022: $535,052
- 2023: $745,904
- 2024: $758,210
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $860.06 in 2021 to $1,261.93 in 2025.
- 2021: $860.06
- 2022: $1,205.60
- 2023: $739.04
- 2024: $735.13
- 2025: $1,261.93
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 37 records totaling $1,261.93.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
REPATHA | General | $147.32 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
BREZTRI | General | $120.25 |
| Kowa Pharmaceuticals America, Inc. |
Food and Beverage
In-kind items and services
|
ZORYVE | General | $120.25 |
| Eli Lilly and Company |
Food and Beverage
Cash or cash equivalent
|
MOUNJARO | General | $119.65 |
| Exact Sciences Corporation |
Food and Beverage
In-kind items and services
|
The Cologuard Plus Collection Kit | General | $119.34 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
OTEZLA | General | $30.84 |
| Abbott Laboratories |
Food and Beverage
In-kind items and services
|
FREESTYLE LIBRE 3 | General | $28.00 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
MOUNJARO | General | $27.44 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
MOUNJARO | General | $26.91 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $26.49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
JARDIANCE | General | $25.48 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
TRELEGY ELLIPTA | General | $25.13 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
MOUNJARO | General | $24.70 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
OTEZLA | General | $24.46 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $24.07 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $23.38 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $21.59 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $21.54 |
| Exact Sciences Corporation |
Food and Beverage
In-kind items and services
|
The Cologuard Plus Collection Kit | General | $20.85 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $20.71 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $20.64 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
SHINGRIX | General | $20.55 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
JARDIANCE | General | $19.67 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $18.91 |
| Paratek Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
NUZYRA | General | $18.81 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
48 | 21 | $150.00 | $131.71 |
|
G0439
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit
|
14 | 14 | $150.00 | $139.99 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 776 | 64,560 | $5,575.90 | 261 |
| Metformin Hcl | Metformin Hcl | 483 | 41,195 | $2,775.92 | 162 |
| Alendronate Sodium | Alendronate Sodium | 278 | 21,351 | $1,628.57 | 92 |
| Naproxen | Naproxen | 213 | 7,075 | $1,535.89 | 95 |
| Levothyroxine Sodium | Levothyroxine Sodium | 206 | 16,332 | $2,413.95 | 63 |
| Losartan Potassium | Losartan Potassium | 177 | 14,830 | $1,167.64 | 67 |
| Jardiance | Empagliflozin | 172 | 12,523 | $238,732.45 | 63 |
| Pioglitazone Hcl | Pioglitazone Hcl | 162 | 13,888 | $1,780.03 | 56 |
| Lisinopril | Lisinopril | 125 | 11,250 | $719.93 | 41 |
| Hydrochlorothiazide | Hydrochlorothiazide | 109 | 8,858 | $715.87 | 41 |
| Ozempic | Semaglutide | 97 | 4,302 | $128,685.07 | 21 |
| Metoprolol Succinate | Metoprolol Succinate | 93 | 7,499 | $1,830.69 | 34 |
| Farxiga | Dapagliflozin Propanediol | 90 | 6,510 | $118,770.30 | 34 |
| Metoprolol Tartrate | Metoprolol Tartrate | 86 | 7,140 | $480.85 | 27 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 86 | 7,511 | $1,624.94 | 29 |
| Tamsulosin Hcl | Tamsulosin Hcl | 85 | 6,318 | $910.35 | 27 |
| Donepezil Hcl | Donepezil Hcl | 78 | 6,652 | $1,311.85 | 27 |
| Valsartan | Valsartan | 69 | 5,876 | $1,716.06 | 25 |
| Ramipril | Ramipril | 63 | 5,040 | $735.94 | 22 |
| Escitalopram Oxalate | Escitalopram Oxalate | 62 | 5,340 | $658.25 | 25 |
| Glipizide | Glipizide | 62 | 5,422 | $362.76 | 23 |
| Gabapentin | Gabapentin | 58 | 4,351 | $823.13 | 23 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 58 | 412 | $284.23 | 45 |
| Azithromycin | Azithromycin | 54 | 270 | $141.73 | 40 |
| Eliquis | Apixaban | 52 | 2,951 | $50,450.11 | 13 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2022-08-04NUCC Taxonomy Code: 208D00000X
A physician who specializes in the general practice of diagnosing, treating, and managing patients with a variety of illnesses and conditions.
NUCC Taxonomy Code: 207Q00000X
Family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity.
NUCC Taxonomy Code: 261QP2300X
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - GENERAL PRACTICE
I20041108001297
CA
8123081361
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 2650 S BRISTOL ST STE 105, SANTA ANA, CA 927045751 (Tel: 7148001919)
NPI status registered as active in NPPES database
Registered at 2650 S BRISTOL ST, SUITE 105, SANTA ANA, CA 92704 (Tel: 7148001919)
Registered at 2650 S BRISTOL ST, SUITE 105, SANTA ANA, CA 927045751 (Tel: 7148001919)
Recorded as ROXANA MINKUS, D.O
Family Medicine (license number reported to NPPES: CA 20A6672)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other General Practices in Santa Ana
- Dr. Joseph Serna, MD
- Dr. Dennis Stolpner, MD
- Dr. Hoai-Ky Ho, MD
- Dr. Ghadir Kinawy, MD
- Dr. David Sanchez, MD
- Dr. Robert Balette, MD
Mailing Address
2650 S Bristol St Ste 105
Santa Ana, CA 927045751
Phone: 7148001919